INNV — Innovage Holding Corp. stock price, charts and financials

NASDAQ·Healthcare·Medical - Care Facilities·USA

Latest market price

10.92

+0.22+2.06%

Overview Short InterestFilings

INNVQT84Innovage Holding Corp.·NASDAQ

Overview Short InterestFilings

10.92+2.06%

News

Up 2.1% — Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock? (Yahoo).

Medium confidence

Loading chart...

Signal & projected range

Earnings big miss — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

AGL-0.01%$89.16 ARDT-2.06%$10.48 HCSG-0.09%$21.47 NUTX-2.58%$208.79 PNTG-1.02%$39.62 AMN-0.84%$34.26 ASTH+0.17%$34.36 SGRY-0.75%$13.25

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.02	Insider Own	-	Shs Outstand	135.74M	Perf Week	1.58%

Market Cap	1.49B	Forward P/E	21.86	EPS next Y	0.50	Insider Trans	0.00%	Shs Float	21.28M	Perf Month	-0.18%

Enterprise Value	1.43B	PEG	-	EPS next Q	0.12	Inst Own	-	Short Float	0.76%	Perf Quarter	21.74%

Income	-2.00M	P/S	1.50	EPS this Y	2301.70%	Inst Trans	-	Short Ratio	3.12	Perf Half Y	30.62%

Sales	990.00M	P/B	5.51	EPS next Y	13.42%	ROA	-0.46%	Short Interest	1.03M	Perf YTD	110.40%

Book/sh	1.98	P/C	10.51	EPS next 5Y	13.42%	ROE	-1.05%	52W High	12.64 -13.61%	Perf Year	119.28%

Cash/sh	1.04	P/FCF	20.16	EPS past 3/5Y	-	ROIC	-44.24%	52W Low	3.94 177.16%	Perf 3Y	73.06%

Dividend Est.	-	EV/EBITDA	46.07	Sales past 3/5Y	12.90% 9.18%	Gross Margin	21.39%	Volatility	4.11% 4.92%	Perf 5Y	-26.96%

Dividend TTM	-	EV/Sales	1.44	EPS Y/Y TTM	90.91%	Oper. Margin	6.39%	ATR (14)	0.56	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	15.93%	Profit Margin	-0.26%	RSI (14)	51.74	Recom	3.11

Dividend Gr. 3/5Y	-	Current Ratio	1.05	EPS Q/Q	175.00%	SMA20	0.71%	Beta	0.09	Target Price	14.00

Payout	0.00%	Debt/Eq	0.32	Sales Q/Q	20.18%	SMA50	-1.24%	Rel Volume	1.09	Prev Close	10.70

Employees	2,500	LT Debt/Eq	0.28	Earnings	Nov 03	SMA200	28.43%	Avg Volume	303.51K	Price	10.92

IPO Date	Mar 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.64% 9.91%	Net Debt/EBITDA	-0.35	Volume	331,563	Change	2.06%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Sep-09-26	Reiterated	Keybanc	Overweight	$13 → $14
Aug-21-26	Upgrade	Keybanc	Sector Weight → Overweight	$13
Dec-17-24	Downgrade	JP Morgan	Neutral → Underweight
Feb-08-23	Reiterated	JP Morgan	Neutral	$8.00
Nov-23-22	Reiterated	Goldman Sachs	Neutral	$8.00
Nov-16-22	Reiterated	Citigroup	Neutral	$8.00
Sep-15-22	Reiterated	Barclays	Equal Weight	$5.00
May-16-22	Downgrade	Baird	Outperform → Neutral
Apr-20-22	Downgrade	Piper Sandler	Neutral → Underweight	$5.00
Dec-28-21	Downgrade	Goldman Sachs	Buy → Neutral

Latest News· Times ET

Sep-16-26

Sep-16-2603:51AM

Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?Yahoo

Sep-10-26

Sep-10-2608:11PM

InnovAge (INNV) Reaches a 9.6% Adjusted EBITDA Margin. Can the PACE Recovery Last?Yahoo

Sep-09-26

Sep-09-2605:04AM

Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga

Sep-08-26

Sep-08-2605:35PM

InnovAge Holding Corp. (INNV) Q4 2026 Earnings Call Transcriptseekingalpha.com

03:04PM

InnovAge Q4 Earnings Call Highlightsmarketbeat.com

02:20PM

InnovAge Holding Corp. (INNV) Misses Q4 Earnings Estimateszacks.com

12:05PM

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026globenewswire.com

Sep-03-26

Sep-03-2611:29PM

BlackRock Inc. Takes Position in InnovAge Holding Corp. $INNVdefenseworld.net

Sep-01-26

Sep-01-2607:01AM

InnovAge Holding Corp. (INNV) Reports Next Week: Wall Street Expects Earnings Growthzacks.com

Aug-26-26

Aug-26-2611:35PM

Algert Global LLC Purchases 563,735 Shares of InnovAge Holding Corp. $INNVdefenseworld.net

04:00AM

InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conferenceglobenewswire.com

Aug-21-26

Aug-21-2606:29AM

This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For FridayBenzinga

Aug-11-26

Aug-11-2604:34PM

InnovAge Holding Corp (INNV) Shares Fall 6.4% -- What GF Score of 62 Tells Investorsgurufocus.com

Aug-04-26

Aug-04-2611:07PM

Arrowstreet Capital Limited Partnership Acquires New Holdings in InnovAge Holding Corp. $INNVdefenseworld.net

Jul-02-26

Jul-02-2608:09AM

InnovAge: A Real Turnaround, But The Stock Now Trades Above Every Analyst TargetSeekingAlpha

Company

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2026 6/30/2026	FY 2025 6/30/2025	FY 2024 6/30/2024	FY 2023 6/30/2023	FY 2022 6/30/2022	FY 2021 6/30/2021	FY 2020 6/30/2020	FY 2019 6/30/2019
Total Revenue	990	990	854	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	779	783	269	—	—	—	—	—	—
Gross Profit	211	207	585	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	201	201	150	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	-53	-61	465	—	—	—	—	—	—
Operating Income	63	66	-30	—	—	—	—	—	—
Interest Expense	4	4	5	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-59	-62	0	—	—	—	—	—	—
Net Income Before Taxes	0	0	-34	—	—	—	—	—	—
Income Taxes	1	1	1	—	—	—	—	—	—
Consolidated Net Income	-2	-3	-30	—	—	—	—	—	—
Net Income From Continuing Operations	0	-1	-35	—	—	—	—	—	—
Net Income	-2	-3	-30	—	—	—	—	—	—
EPS (Recurring)	-0.02	-0.02	-0.22	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.02	-0.02	-0.22	—	—	—	—	—	—
EPS (Diluted)	-0.02	-0.02	-0.22	—	—	—	—	—	—
EBITDA	31	87	3	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	1.50	1.63	0.58	—	—	—	—	—	—
Gross Margin	21.31	20.91	68.50	—	—	—	—	—	—
Operating Margin	6.36	6.67	-3.51	—	—	—	—	—	—
Net Margin	-0.20	-0.30	-3.51	—	—	—	—	—	—
Shares Outstanding	136	136	135	—	—	—	—	—	—
Market Capitalization	1,485	1,612	498	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCARBROUGH MICHAEL ANTHONY	President and COO	Nov 14 '25	Sale	4.90	33,000	161,700	119,617	Nov 17
ZORETIC RICHARD C	Director	May 30 '25	Buy	4.08	8,450	34,476	68,494	May 30
ZORETIC RICHARD C	Director	May 29 '25	Buy	4.04	14,265	57,631	60,044	May 30
ZORETIC RICHARD C	Director	May 28 '25	Buy	4.06	20,000	81,200	45,779	May 30
ZORETIC RICHARD C	Director	May 23 '25	Buy	3.93	1,198	4,708	25,779	May 23
ZORETIC RICHARD C	Director	May 22 '25	Buy	4.09	700	2,863	24,581	May 23
ZORETIC RICHARD C	Director	May 21 '25	Buy	4.13	1,147	4,737	23,881	May 23
ZORETIC RICHARD C	Director	May 20 '25	Buy	4.20	807	3,389	22,734	May 20
ZORETIC RICHARD C	Director	May 16 '25	Buy	4.28	2,086	8,928	21,927	May 20
SCARBROUGH MICHAEL ANTHONY	President and COO	May 13 '25	Buy	3.89	10,000	38,900	33,000	May 13
SCARBROUGH MICHAEL ANTHONY	President and COO	May 12 '25	Buy	3.73	13,000	48,490	23,000	May 13
SCARBROUGH MICHAEL ANTHONY	President and COO	May 09 '25	Buy	3.55	10,000	35,500	10,000	May 13
DAMATO NICOLE	CHIEF LEGAL OFFICER	Nov 06 '24	Sale	6.54	1,660	10,856	231,614	Nov 08
DAMATO NICOLE	Chief Legal Officer	Sep 17 '24	Sale	6.00	7,521	45,126	233,274	Sep 18
DAMATO NICOLE	Chief Legal Officer	Sep 16 '24	Sale	5.95	4,372	26,013	240,795	Sep 18

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.